Christopher Richard Anzalone Insider Trading for September 2019
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Christopher Richard Anzalone.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Christopher Richard Anzalone for September 2019.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 27 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 28.25 | 20,000 | 565,000 | 2,121,903 | 2.1 M to 2.1 M (-0.93 %) |
| Sep 27 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 28.25 | 20,000 | 565,000 | 2,121,903 | 2.1 M to 2.1 M (-0.93 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 5.10 | 66,645 | 339,890 | 1,001,868 | |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 5.10 | 41,755 | 212,951 | 1,068,513 | |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 5.10 | 66,645 | 339,890 | 1,001,868 | |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 5.10 | 4,250 | 21,675 | 1,110,268 | |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 5.10 | 41,755 | 212,951 | 1,068,513 | |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 29.04 | 12,673 | 368,024 | 2,141,903 | 2.2 M to 2.1 M (-0.59 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Option Exercise | M | 5.10 | 4,250 | 21,675 | 1,110,268 | |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 28.00 | 53,972 | 1,511,216 | 2,154,576 | 2.2 M to 2.2 M (-2.44 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 29.04 | 12,673 | 368,024 | 2,141,903 | 2.2 M to 2.1 M (-0.59 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 5.10 | 66,645 | 339,890 | 2,208,548 | 2.1 M to 2.2 M (+3.11 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 28.00 | 53,972 | 1,511,216 | 2,154,576 | 2.2 M to 2.2 M (-2.44 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 29.04 | 41,755 | 1,212,565 | 2,141,903 | 2.2 M to 2.1 M (-1.91 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 5.10 | 66,645 | 339,890 | 2,208,548 | 2.1 M to 2.2 M (+3.11 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 5.10 | 41,755 | 212,951 | 2,183,658 | 2.1 M to 2.2 M (+1.95 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 29.04 | 41,755 | 1,212,565 | 2,141,903 | 2.2 M to 2.1 M (-1.91 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 29.00 | 4,250 | 123,250 | 2,141,903 | 2.1 M to 2.1 M (-0.20 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 5.10 | 41,755 | 212,951 | 2,183,658 | 2.1 M to 2.2 M (+1.95 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 5.10 | 4,250 | 21,675 | 2,146,153 | 2.1 M to 2.1 M (+0.20 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Sell | S | 29.00 | 4,250 | 123,250 | 2,141,903 | 2.1 M to 2.1 M (-0.20 %) |
| Sep 24 2019 | ARWR | ARROWHEAD PHARMACE ... | Anzalone Christopher Richard | Chief Executive Off ... | Buy | M | 5.10 | 4,250 | 21,675 | 2,146,153 | 2.1 M to 2.1 M (+0.20 %) |